What question did this study set out to answer?

To estimate cumulative population immunity against COVID-19 and identify individual demographic characteristics associated with positive anti-SARS-CoV-2 serostatus.

June 5, 2023Journal of Public Health in AfricaOpen Access

Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic

View Full Paper

Ask AI

Bookmark

To estimate cumulative population immunity against COVID-19 and identify individual demographic characteristics associated with positive anti-SARS-CoV-2 serostatus.
Conducted a clustered cross-sectional household survey involving 799 participants in Bangui, Central African Republic, between July and August 2021.
Collected demographic data, comorbidity profiles, and venous blood samples.
Assayed total anti-SARS-CoV-2 antibody levels using the WANTAI SARS-CoV-2 Ab enzyme-linked immunosorbent assay (ELISA) kit.
The overall proportion of participants with positive anti-SARS-CoV-2 serostatus reached 74.1% in a cohort with an average age of 27 years and 45.8% male participation.
Participants older than 20 years had significantly higher odds of seropositivity compared with younger individuals (odds ratio: 2.2; 95% CI: 1.6 to 3.1).

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Clustered cross-sectional study reveals widespread anti-SARS-CoV-2 seropositivity across urban households, indicating substantial community transmission and high presumptive immunity.

Cite This Study

Manirakiza et al. (2023) studied this question.

synapsesocial.com/papers/6a96f551934adeec1901fbf3 https://doi.org/10.4081/jphia.2023.2315

View Full Paper

Ask AI

Bookmark

Implication

Clustered cross-sectional study reveals widespread anti-SARS-CoV-2 seropositivity across urban households, indicating substantial community transmission and high presumptive immunity.

Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic

Key Points

Discussion

Implication

Cite This Study

Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider